{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T09:38:46Z","timestamp":1792748326371,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.pharma.2025.12.013","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T07:39:14Z","timestamp":1766389154000},"page":"1010-1022","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ocular cationic nanocarrier-based delivery of posaconazole"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6919-1333","authenticated-orcid":false,"given":"Sagar","family":"Kothawade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashlesha","family":"Pandit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udhav","family":"Bagul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pravin","family":"Badhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharma.2025.12.013_bib0240","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/hsr2.529","article-title":"Retracted: mucormycosis infection in patients with COVID-19: a systematic review","volume":"5","author":"Seyed Alinaghi","year":"2022","journal-title":"Health Sci Rep"},{"key":"10.1016\/j.pharma.2025.12.013_bib0245","doi-asserted-by":"crossref","first-page":"907","DOI":"10.3390\/jof7110907","article-title":"Recent perspectives in the management of fungal keratitis","volume":"7","author":"Raj","year":"2021","journal-title":"J Fungi"},{"key":"10.1016\/j.pharma.2025.12.013_bib0250","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1093\/clinids\/14.5.1069","article-title":"Cryptococcal endophthalmitis: case report and review","volume":"14","author":"Crump","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.pharma.2025.12.013_bib0255","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3390\/jof8111121","article-title":"Ibrexafungerp, a novel triterpenoid antifungal in development for the treatment of mold infections","volume":"8","author":"Angulo","year":"2022","journal-title":"J Fungi"},{"key":"10.1016\/j.pharma.2025.12.013_bib0260","doi-asserted-by":"crossref","first-page":"105093","DOI":"10.1016\/j.jddst.2023.105093","article-title":"Novel itraconazole nano-spanlastics gel with enhanced penetration to treat topical fungal infection","volume":"90","author":"Dhakane","year":"2023","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.pharma.2025.12.013_bib0265","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2147\/IJN.S100625","article-title":"Miconazole-loaded solid lipid nanoparticles: formulation and evaluation of a novel formula with high bioavailability and antifungal activity","volume":"11","author":"Aljaeid","year":"2016","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.pharma.2025.12.013_bib0270","doi-asserted-by":"crossref","first-page":"102561","DOI":"10.1016\/j.jddst.2021.102561","article-title":"Enhanced ocular delivery of clotrimazole via loading into mucoadhesive microemulsion system: in vitro characterization and in vivo assessment","volume":"64","author":"Al-mahallawi","year":"2021","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.pharma.2025.12.013_bib0275","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/s13346-021-00974-x","article-title":"Posaconazole micelles for ocular delivery: in vitro permeation, ocular irritation and antifungal activity studies","volume":"12","author":"Durgun","year":"2022","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.pharma.2025.12.013_bib0280","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/14656566.2021.1996562","article-title":"Evaluating posaconazole, its pharmacology, efficacy and safety for the prophylaxis and treatment of fungal infections","volume":"23","author":"Panagopoulou","year":"2022","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.pharma.2025.12.013_bib0285","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1439-0507.2006.01295.x","article-title":"A new, broad-spectrum azole antifungal: posaconazole\u00a0\u2013\u00a0mechanisms of action and resistance, spectrum of activity","volume":"49","author":"Hof","year":"2006","journal-title":"Mycoses"},{"key":"10.1016\/j.pharma.2025.12.013_bib0290","doi-asserted-by":"crossref","first-page":"11242","DOI":"10.1021\/cr5003134","article-title":"Drug strategies targeting CYP51 in neglected tropical diseases","volume":"114","author":"Choi","year":"2014","journal-title":"Chem Rev"},{"key":"10.1016\/j.pharma.2025.12.013_bib0295","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/jms.280","article-title":"Mechanism of azole antifungal activity as determined by liquid chromatographic\/mass spectrometric monitoring of ergosterol biosynthesis","volume":"37","author":"Heimark","year":"2002","journal-title":"J Mass Spectrom"},{"key":"10.1016\/j.pharma.2025.12.013_bib0300","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1128\/AAC.48.2.568-574.2004","article-title":"Three-dimensional models of wild-type and mutated forms of cytochrome P450 14\u03b1-sterol demethylases from Aspergillus fumigatus and Candida albicans provide insights into posaconazole binding","volume":"48","author":"Xiao","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pharma.2025.12.013_bib0305","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3390\/pharmaceutics11090460","article-title":"Advanced formulation approaches for ocular drug delivery: state-of-the-art and recent patents","volume":"11","author":"Souto","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.pharma.2025.12.013_bib0310","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1208\/s12249-023-02516-9","article-title":"Ocular drug delivery: a comprehensive review","volume":"24","author":"Ahmed","year":"2023","journal-title":"AAPS Pharm Sci Tech"},{"key":"10.1016\/j.pharma.2025.12.013_bib0315","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.2217\/nnm.11.38","article-title":"Lecithin-based novel cationic nanocarriers (LeciPlex) I: fabrication, characterization and evaluation","volume":"6","author":"Date","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/j.pharma.2025.12.013_bib0320","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.colsurfb.2010.02.013","article-title":"Biological activity of SDS-CTAB cat-anionic vesicles in cultured cells and assessment of their cytotoxicity ending in apoptosis","volume":"78","author":"Aiello","year":"2010","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.pharma.2025.12.013_bib0325","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1080\/09273948.2021.1957124","article-title":"Review of preclinical outcomes of a topical cationic emulsion of cyclosporine A for the treatment of ocular surface diseases","volume":"30","author":"Daull","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.pharma.2025.12.013_bib0330","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0753-3322(99)80088-2","article-title":"Prevention of topical and ocular oxidative stress by positively charged submicron emulsion","volume":"53","author":"Benita","year":"1999","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.pharma.2025.12.013_bib0335","doi-asserted-by":"crossref","first-page":"124147","DOI":"10.1016\/j.ijpharm.2024.124147","article-title":"Impact of formulation parameters on self-assembled liposomes (LeciPlex\u00ae III): a detailed investigation","volume":"657","author":"Katawale","year":"2024","journal-title":"Int J Pharm"},{"key":"10.1016\/j.pharma.2025.12.013_bib0340","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1021\/mp100305h","article-title":"Lecithin-based novel cationic nanocarriers (Leciplex) II: improving therapeutic efficacy of quercetin on oral administration","volume":"8","author":"Date","year":"2011","journal-title":"Mol Pharm"},{"key":"10.1016\/j.pharma.2025.12.013_bib0345","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.3390\/pharmaceutics14102215","article-title":"Sertaconazole-nitrate-loaded leciplex for treating keratomycosis: optimization using D-optimal design and in vitro, ex vivo, and in vivo studies","volume":"14","author":"Abdellatif","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.pharma.2025.12.013_bib0350","first-page":"105598","article-title":"pH measurement and phosphate determination in pharmaceutical eye drops for eye diseases by digital image analysis","volume":"162","author":"Berasarte Urroz","year":"2020","journal-title":"Microchem J"},{"key":"10.1016\/j.pharma.2025.12.013_bib0355","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/pharmaceutics10040197","article-title":"Formulation and characterization of carvedilol leciplex for glaucoma treatment: in vitro, ex vivo and in vivo study","volume":"10","author":"Hassan","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.pharma.2025.12.013_bib0360","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jcis.2021.04.081","article-title":"Nanoparticle size distribution quantification from transmission electron microscopy (TEM) of ruthenium tetroxide stained polymeric nanoparticles","volume":"604","author":"Wilson","year":"2021","journal-title":"J Colloid Interface Sci"},{"key":"10.1016\/j.pharma.2025.12.013_bib0365","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40199-014-0087-0","article-title":"Formulation and optimization of itraconazole polymeric lipid hybrid nanoparticles (Lipomer) using box behnken design","volume":"23","author":"Gajra","year":"2015","journal-title":"DARU J Pharm Sci"},{"key":"10.1016\/j.pharma.2025.12.013_bib0370","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2147\/DDDT.S264745","article-title":"New approach in ocular drug delivery: in vitro and ex vivo investigation of cyclodextrin-containing, mucoadhesive eye drop formulations","volume":"15","author":"B\u00edr\u00f3","year":"2021","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.pharma.2025.12.013_bib0375","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-010-9413-0","article-title":"In situ gelling gelrite\/alginate formulations as vehicles for ophthalmic drug delivery","volume":"11","author":"Liu","year":"2010","journal-title":"AAPS Pharm Sci Tech"},{"key":"10.1016\/j.pharma.2025.12.013_bib0380","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00769-025-01676-4","article-title":"Quality by design-assisted stability-indicating RP-HPLC method development and validation of posaconazole and its related substances in active pharmaceutical ingredient","volume":"30","author":"Gandi","year":"2025","journal-title":"Accredit Qual Assur"},{"key":"10.1016\/j.pharma.2025.12.013_bib0385","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jconrel.2005.11.020","article-title":"W\/O microemulsions for ocular delivery: evaluation of ocular irritation and precorneal retention","volume":"111","author":"Alany","year":"2006","journal-title":"J Control Release"},{"key":"10.1016\/j.pharma.2025.12.013_bib0390","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.mimet.2019.01.020","article-title":"Antifungal efficacy of itraconazole loaded PLGA-nanoparticles stabilized by vitamin-E TPGS: in vitro and ex vivo studies","volume":"161","author":"Alhowyan","year":"2019","journal-title":"J Microbiol Methods"},{"key":"10.1016\/j.pharma.2025.12.013_bib0395","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1089\/jop.2020.0043","article-title":"High-frequency application of cationic agents containing lubricant eye drops causes cumulative corneal toxicity in an ex vivo eye irritation test model","volume":"36","author":"Dutescu","year":"2020","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.pharma.2025.12.013_bib0400","series-title":"The isolated chicken eye test to replace the Draize test in rabbits: from development to implementation: the long and winding road","author":"Prinsen","year":"2014"},{"key":"10.1016\/j.pharma.2025.12.013_bib0405","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.colsurfb.2011.01.009","article-title":"Surface coverage of didecyl dimethylammonium bromide on poly(lactide-co-glycolide) nanoparticles","volume":"84","author":"Kuo","year":"2011","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.pharma.2025.12.013_bib0410","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.chemphyslip.2011.07.002","article-title":"Characterization of cationic liposomes. Influence of the bilayer composition on the kinetics of the liposome breakdown","volume":"164","author":"Angelini","year":"2011","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/j.pharma.2025.12.013_bib0415","doi-asserted-by":"crossref","first-page":"124391","DOI":"10.1016\/j.ijpharm.2024.124391","article-title":"Fabrication of acetazolamide loaded leciplex for intraocular delivery: optimization by 32 full factorial design, in vitro, ex vivo and in vivo pharmacodynamics","volume":"661","author":"Bagul","year":"2024","journal-title":"Int J Pharm"},{"key":"10.1016\/j.pharma.2025.12.013_bib0420","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ejps.2018.01.039","article-title":"Evaluation and optimized selection of supersaturating drug delivery systems of posaconazole (BCS class 2b) in the gastrointestinal simulator (GIS): an in vitro-in silico-in vivo approach","volume":"115","author":"Hens","year":"2018","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.pharma.2025.12.013_bib0425","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.tifs.2021.02.028","article-title":"Inter-relationships between composition, physicochemical properties and functionality of lecithin ingredients","volume":"111","author":"Bot","year":"2021","journal-title":"Trends Food Sci Technol"},{"key":"10.1016\/j.pharma.2025.12.013_bib0430","first-page":"101087","article-title":"Overcoming corneal barriers: posaconazole loaded cationic surfactant vesicles for enhanced ocular permeability and anti-fungal efficacy","volume":"20","author":"Phatak","year":"2025","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.pharma.2025.12.013_bib0435","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/ACI.0b013e32830e6b04","article-title":"Functions of ocular surface mucins in health and disease","volume":"8","author":"Mantelli","year":"2008","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.pharma.2025.12.013_bib0440","doi-asserted-by":"crossref","first-page":"118943","DOI":"10.1016\/j.ijpharm.2019.118943","article-title":"Mucoadhesive dexamethasone-glycol chitosan nanoparticles for ophthalmic drug delivery","volume":"575","author":"Yu","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/j.pharma.2025.12.013_bib0445","doi-asserted-by":"crossref","first-page":"9435","DOI":"10.1021\/acsanm.2c01715","article-title":"Itraconazole nanocrystals on hydrogel contact lenses via inkjet printing: implications for ophthalmic drug delivery","volume":"5","author":"Tetyczka","year":"2022","journal-title":"ACS Appl Nano Mater"},{"key":"10.1016\/j.pharma.2025.12.013_bib0450","doi-asserted-by":"crossref","first-page":"101910","DOI":"10.1016\/j.jddst.2020.101910","article-title":"Development of acetazolamide loaded bilosomes for improved ocular delivery: preparation, characterization and in vivo evaluation","volume":"59","author":"Mohsen","year":"2020","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.pharma.2025.12.013_bib0455","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1208\/s12249-009-9266-6","article-title":"Development of an ex vivo method for evaluation of precorneal residence of topical ophthalmic formulations","volume":"10","author":"Liu","year":"2009","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.pharma.2025.12.013_bib0460","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0887-2333(00)00029-1","article-title":"Corneal opacity, hydration and endothelial morphology in the bovine cornea opacity and permeability assay using reduced treatment times","volume":"14","author":"Ubels","year":"2000","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.pharma.2025.12.013_bib0465","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0924-8579(01)00363-6","article-title":"In vitro antifungal activity of posaconazole against various pathogenic fungi","volume":"18","author":"Uchida","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.pharma.2025.12.013_bib0470","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.preteyeres.2017.06.004","article-title":"The chick eye in vision research: an excellent model for the study of ocular disease","volume":"61","author":"Wisely","year":"2017","journal-title":"Prog Retin Eye Res"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450925002226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450925002226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T08:42:20Z","timestamp":1792744940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450925002226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0003450925002226"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2025.12.013","relation":{},"ISSN":["0003-4509"],"issn-type":[{"value":"0003-4509","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ocular cationic nanocarrier-based delivery of posaconazole","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2025.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Acad\u00e9mie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}